Effect of pro-inflammatory cytokine-mediated mechanism on quality of gastrointestinal restitutio ad integrum

Annales Universitatis Mariae Curie-Sklodowska, Sectio DDD: Pharmacia

Volumn 23, Issue 3, 2010, Pages 211-214

  Hrytsevych, Nazar ^a   Zvir, Maryana ^a   Zayachkivska, Oksana ^a   Gzhgotskyi, Mechyslav ^a  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Esophageal mucosa; Melatonin; Ulcer

Indexed keywords

INTERLEUKIN 1BETA; LECTIN; MELATONIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; IMMOBILIZATION STRESS; MALE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; REFLUX ESOPHAGITIS; SIGNAL TRANSDUCTION; WATER IMMERSION RESTRAINT STRESS;

EID: 84860459116     PISSN: 08670609     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Baatar D., et al.: Esophageal ulceration triggers expression of hypoxia-inducible factor la and activates vascular endothelial growth factor gene: implications for angiogenesis and ulcer healing. Am. J. Pathol., 161, 1449, 2002.
2. Bubenik G. A.: Therapeutic perspectives of gastrointestinal melatonin. Melatonin: from molecules to therapy. Eds: R. S. Pandi-Perumal, D. P. Cardinali, Nova Publishers 2006.
3. Carrillo-Vico A., Guerrero J. M., Lardone P. J., Reiter R. J.: A review of the multiple actions of melatonin on the immune system. Endocrinology, 27, 189, 2005.
4. De Filippis D., et al.: Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. J. Pineal. Res., 44, 45, 2008.
5. Erren T. C., Reiter R. J.: Light Hygiene: Time to make preventive use of insights-old and new-into the nexus of the drug light, melatonin, clocks, chronodisruption and public health. Med. Hypoth., 73, 537, 2009.
6. Konturek S. J., Zayachkivska O. S., Brzozowski T. et al.: Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. J. Physiol. Pharmacol., 58, 371, 2007.
7. Konturek S. J., Konturek P. C., Brzozowska I., Pawlik M.: Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J. Physiol. Pharmacol., 58, 381, 2007.
8. Mayo J. C., Sainz R. M., Tan D. X., et al.: Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK) in macrophages. J. Neuroimmunol., 165, 39, 2005.
9. Motilva V., Cabeza J., Alarcon de la Lastra C.: New issues about melatonin and its effect on the digestive system. Curr. Pharmaceut. Design., 7, 909, 2001.
10. Perianayagam M. C., Oxenkrug G. F., Jaber B. L.: Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine. Ann. N. Y. Acad. Sci., 1053, 386, 2005.
11. Zayachkivska O., Gzhegotsky M., Yaschenko A. et al.: Effects of nitrosative stress and reactive oxygenscavenging systems (ROSS) in esophageal physiopathy under streptozotocin-induced experimental hyperglycemia. J. Physiol. Pharmacol., 59, 77, 2008.